Trademark: ZILBRYSQ
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ZILBRYSQ
We do not have any records of a proof of use for ZILBRYSQ at this moment.
Possible trademark infringements of ZILBRYSQ
Basic Information about ZILBRYSQ
- Serial Number
- 88850346
- Filing Date
- 27 Mar 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ZILBRYSQ on the blockchain with WikiTrademarks.io.
- First use of ZILBRYSQ anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of ZILBRYSQ anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns ZILBRYSQ?
1. Ra Pharmaceuticals, Inc. Cambridge MA
2. Ra Pharmaceuticals, Inc. Cambridge MA
Correspondent
- Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.
- 1025 Connecticut Avenue, NW, Suite 500
- Washington, DC 20036
- UNITED STATES
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io